Tenaya Therapeutics, Inc. (TNYA)
0.66
-0.03
(-4.98%)
USD |
NASDAQ |
Apr 06, 16:00
0.687
+0.03
(+4.09%)
After-Hours: 20:00
Tenaya Therapeutics SG&A Expense (TTM) : 24.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.185M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| Savara, Inc. | 42.06M |
| Vericel Corp. | 166.99M |
| BioMarin Pharmaceutical, Inc. | 1.153B |